An international consortium of industry-leading companies
The TVG regional affiliate program is an international consortium of regional trade and business development organizations focused on promoting the growth of the life science and biotechnology industries worldwide. Regional affiliates include important industry associations and government institutions in every major biotech hub, across thirteen countries. Through our regional affiliates we can help you connect with companies, potential business partners, government representatives, and supporting regional networks wherever the life science industry is expanding.
Niaba
Netherlandshttp://www.niaba.nl
Niaba is the Netherlands' Biotech Industry Association. With more than 60 members it represents the majority of the Dutch biotechnological companies and related organisations in human and animal healthcare, food, feed, agriculture and environment. Among its members are not only large multinationals companies such as Unilever and Akzo Nobel, but also small biotechnological companies, major research institutes and associations in related sectors. Niaba is active in the fields of lobbying and advising governments, but also on issues such as research and development. Furthermore Niaba focuses on communication with the general public on biotechnology.
BayBio2010 | Life Science Innovation: Drivers and Barriers
April 7, 2010San Francisco, CA
http://www.baybio.org/wt/page/BayBio2010
BayBio2010 is a one-day conference focusing on Northern California's strength in life sciences innovation.
This conference will examine the fundamental questions of who pays for biotech innovation and why in this unprecedented environment. It will focus on how the current financing environment and new sources of capital affect business models, development and commercialization strategies.
November 12, 2009
AusBiotech 2009 Confirms Biotech Sector in Recovery
The AusBiotech 2009 conference has confirmed the Australian biotechnology sector is on the rise again, having survived the economic downturn and emerging stronger than before. 1423 delegates from 30 countries around the world gathered in Melbourne from 27-30 October for the industrys premier biotechnology conference in the Asia Pacific region. The event was a resounding success and a fantastic showcase of local research and development, highlighting the investment potential of both the early and late stage work currently taking place in Australia, said Dr Anna Lavelle, CEO AusBiotech.
The conference provided invaluable opportunities for relationships and partnerships to be forged amongst representatives from Australian biotechs and international and local investors and pharmaceutical companies. More than 3680 meetings were requested throughout the duration of the conference, with 2159 confirmed through the Business Matching Program.
Following the success of last years conference, AusBiotech 2009 was yet another great event. Importantly it demonstrated the recovery of the biotech industry out of the economic downturn and pointed to the emergence of a stronger sector than ever before as a result of local R&D successes close to market and increased investment in Australian companies, said Dr Lavelle.
